02/06/2026
Uncontrolled haemorrhage remains one of the leading causes of preventable death following traumatic injury.
In the pre-hospital environment, definitive surgical bleeding control is not available. Rapid haemorrhage control is — and that relies on equipment being accessible, compact, and deployable under pressure.
SpeedM is listed on the Australian Register of Therapeutic Goods (ARTG entry 472226) as a Class IIa device for heavily bleeding traumatic wounds.
Its mechanism of action is based on Halloysite Nano Tubes (HNT), a mineral compound applied to a cellulose nonwoven via precision printing. The HNT structure concentrates platelets through electrostatic attraction, supporting the body's natural clotting response. The reaction is non-exothermic, contains no animal proteins, no human proteins, and no shellfish derivatives.
Supplied in a vacuum-sealed Z-fold format (7.5cm x 370cm) designed for rapid application. No refrigeration required.
Available through Midmed. Confirm current availability with your sales consultant.
For product information or to request a clinical evaluation: buff.ly/gSHNqxD